Literature DB >> 20683214

Clear cell meningiomas: three case reports with genetic characterization and review of the literature.

Shigeo Ohba1, Hikaru Sasaki, Tokuhiro Kimura, Eiji Ikeda, Takeshi Kawase.   

Abstract

BACKGROUND AND IMPORTANCE: Intracranial clear cell meningioma is very rare. We present 3 cases of intracranial clear cell meningiomas genetically characterized by comparative genomic hybridization with a review of the literature. CLINICAL
PRESENTATION: Patient 1 is a 38-year-old woman with a petroclival tumor. Patient 2 is a 60-year-old man with a tumor at the foramen magnum. Patient 3 is a 60-year-old man with a tumor at the posterior clinoid process. Gross total resection was performed in patients 1 and 2. Patient 1 has been free from recurrence for 10 years. Patient 2 had a tumor recurrence at 14 months after the operation. After partial resection, conventional radiotherapy was given, and there was no tumor regrowth at 2 years after radiotherapy. Subtotal resection was performed in patient 3, and no regrowth was detected for 3 months. Histologically, all tumors were composed of cells with clear cytoplasm reactive for periodic acid-Schiff and diagnosed as clear cell meningioma. The MIB-1 and p53 staining indexes were 1.8, 1.7, and 5.6 and 1.1, 1.0, and 5.5, respectively. Comparative genomic hybridization revealed no chromosomal number aberrations in patient 1, numerous losses and gains including loss of chromosome 1 in patient 2, and loss of only 22q in patient 3. Because staining indexes of MIB-1 and p53 were equivalent in 2 patient (patients 1 and 2) with a long follow-up period, the contrary clinical courses are likely associated with genetic characteristics.
CONCLUSION: To the best of our knowledge, this is the first report that suggests association between tumor behavior and genetic characteristics in clear cell meningiomas.

Entities:  

Mesh:

Year:  2010        PMID: 20683214     DOI: 10.1227/01.NEU.0000374857.06732.CD

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  7 in total

1.  Paediatric clear cell meningioma with multiple distant recurrences after presumed intra-operative cell spread.

Authors:  Onno Küster; Jens Schittenhelm; Oliver Schwartz; Richard Meyermann; Martin U Schuhmann
Journal:  Childs Nerv Syst       Date:  2012-01-05       Impact factor: 1.475

2.  Intracranial clear cell meningioma in two children with blood relations: two case reports and literature review.

Authors:  Zhiqi Li; Yi Zhang; Enming Wang; Zhiqiu Wang; Wengang Li; Shan Huang; Jun Li
Journal:  Childs Nerv Syst       Date:  2012-07-20       Impact factor: 1.475

Review 3.  Characteristics and surgical strategies for posterior clinoid process meningioma: two case reports and review of the literature.

Authors:  Hajime Takase; Takafumi Kawasaki; Kensuke Tateishi; Taka-Akira Yokoyama; Hidetoshi Murata; Nobutaka Kawahara
Journal:  Neurosurg Rev       Date:  2016-08-24       Impact factor: 3.042

4.  Clear cell histology portends a worse prognosis than other WHO grade II histologies.

Authors:  Pranay Soni; Jianning Shao; Arbaz Momin; Diana Lopez; Lilyana Angelov; Alireza M Mohammadi; Gene H Barnett; Pablo F Recinos; Varun R Kshettry
Journal:  J Neurooncol       Date:  2021-01-04       Impact factor: 4.130

5.  Molecular progression in unusual recurrent non-pediatric intracranial clear cell meningioma.

Authors:  B Domingo-Arrué; R Gil-Benso; J Megías; L Navarro; T San-Miguel; L Muñoz-Hidalgo; C López-Ginés; M Cerdá-Nicolás
Journal:  Curr Oncol       Date:  2017-06-27       Impact factor: 3.677

Review 6.  Rare intraspinal clear cell meningioma in children: a case report and literature review.

Authors:  Zheng Hao; Si Hu; Nian-Zu Yu
Journal:  J Int Med Res       Date:  2020-10       Impact factor: 1.671

7.  Spinal clear cell meningioma without dural attachment: a case report and literature review.

Authors:  Kais Maamri; Mohamed Amine Hadj Taieb; Amine Trifa; Ghassen Elkahla; Manel Njima; Mehdi Darmoul
Journal:  Radiol Case Rep       Date:  2022-03-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.